Aardvark Therapeutics Inc. (AARD)
NASDAQ: AARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AARD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $108.55M
- EPS (TTM)
- -$3.21
- Dividend yield
- None
- 52-week range
- 3.35 – 17.94
- Day range
- 4.70 – 5.33
- Volume / Avg
- 212.04K / 210.14K
- Beta
- —
- Shares outstanding
- 21.88M
- Next earnings
- Nov 12, 2026
52-week range
AARD stock today
Aardvark Therapeutics (AARD) closed at $4.96 on Oct 7, down 1.59% (-$0.08), versus the S&P 500's 0.22% decline. At this level, AARD sits near the bottom of its 52-week range of $3.35 to $17.94: 72.4% below the high, set on Oct 8, 2025 and 48.1% above the low. AARD is down 62.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 71.5%.
Aardvark Therapeutics has posted a net loss over the last twelve months (EPS of -$3.21), so its P/E ratio is not meaningful. Aardvark Therapeutics's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Aardvark Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2025
Earnings
Earnings history- Next report
- Nov 12, 2026
AARD news
All AARD newsAardvark Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PMVPPMV Pharmaceuticals Inc. | 1.50 | -6.83% | $113.27M | vs AARD |
| GNLXGenelux Corporation | 2.52 | -0.79% | $114.02M | vs AARD |
| RANIRani Therapeutics Holdings Inc. Class A | 0.8121 | -2.02% | $114.12M | vs AARD |
| CRBPCorbus Pharmaceuticals Holdings Inc. | 5.49 | -5.02% | $106.18M | vs AARD |
| KZIAKazia Therapeutics Limited ADR | 9.29 | +0.32% | $106.16M | vs AARD |
| UNCYUnicycive Therapeutics Inc. | 4.18 | -1.18% | $114.50M | vs AARD |
| COYACoya Therapeutics Inc. | 4.91 | +1.24% | $115.18M | vs AARD |
| PLYXPolaryx Therapeutics Inc. | 2.09 | -0.48% | $104.18M | vs AARD |
Indexes, lists and sector
Largest Health Care stocks
Aardvark Therapeutics stock FAQ
What is Aardvark Therapeutics's stock price today?
AARD last traded at $4.96 as of Oct 7, 4:00 PM EDT, down 1.59% on the day. Prices are delayed at least 15 minutes.
When is Aardvark Therapeutics's next earnings date?
Aardvark Therapeutics is expected to report earnings on Thursday, November 12, 2026.
What is the AARD 52-week high?
The 52-week high for AARD is $17.94 and the 52-week low is $3.35. The stock is currently 72.4% below its high.